Identification of two antagonists of the scavenger receptor CD36 using a high-throughput screening model

Analytical Biochemistry

Volumn 400, Issue 2, 2010, Pages 207-212

  Xu, Yanni ^a   Wang, Juan ^a   Bao, Yi ^a   Jiang, Wei ^a   Zuo, Lian ^a   Song, Danqing ^a   Hong, Bin ^a   Si, Shuyi ^a  

^a INSTITUTE OF MEDICINAL BIOTECHNOLOGY   (China)

Author keywords

Antagonist; Atherosclerosis; CD36; High throughput screening

Indexed keywords

DISEASES; INORGANIC COMPOUNDS; LIPOPROTEINS; MACROPHAGES; MOLECULAR BIOLOGY;

ANTAGONIST; ATHEROSCLEROSIS; BACULOVIRUS EXPRESSION SYSTEMS; CD36; CHINESE HAMSTER OVARY CELLS; HIGH THROUGHPUT SCREENING; HIGH-DENSITY LIPOPROTEINS; INTEGRAL MEMBRANE PROTEINS;

CYTOLOGY;

1,1' DIOCTADECYL 3,3,3',3' TETRAMETHYLINDOCARBOCYANINE; 13 PENTYL BERBERINE; 3 CINNAMOYL INDOLE; ACETYL LOW DENSITY LIPOPROTEIN; BERBERINE DERIVATIVE; CD36 ANTIGEN; HIGH DENSITY LIPOPROTEIN; INDOLE DERIVATIVE; LIPOPROTEIN; MEMBRANE PROTEIN; SCAVENGER RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; BACULOVIRUS EXPRESSION SYSTEM; CELL ASSAY; CHO CELL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG RESEARCH; DRUG STRUCTURE; ENDOCYTOSIS; FEMALE; FOAM CELL; HIGH THROUGHPUT SCREENING; IC 50; INHIBITION KINETICS; INSECT CELL; LEPIDOPTERA; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION;

CRICETULUS GRISEUS; HEXAPODA; MURINAE; SPODOPTERA FRUGIPERDA;

EID: 77950691316     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2010.02.003     Document Type: Article

References (27)

1. Martin C.A., Longman E., Wooding C., Hoosdally S.J., Ali S., Aitman T.J., Gutmann D.A., Freemont P.S., Byrne B., Linton K.J. Cd36, a class B scavenger receptor, functions as a monomer to bind acetylated and oxidized low-density lipoproteins. Protein Sci. 2007, 16:2531-2541.
2. Sun B., Boyanovsky B.B., Connelly M.A., Shridas P., van der Westhuyzen D.R., Webb N.R. Distinct mechanisms for OxLDL uptake and cellular trafficking by class B scavenger receptors CD36 and SR-BI. J. Lipid Res. 2007, 48:2560-2570.
3. Fernández-Ruiz E., Armesilla A.L., Sánchez-Madrid F., Vega M.A. Gene encoding the collagen type I and thrombospondin receptor CD36 is located on chromosome 7q11.2. Genomics 1993, 17:759-761.
4. Armesilla A.L., Vega M.A. Structural organization of the gene for human CD36 glycoprotein. J. Biol. Chem. 1994, 269:18985-18991.
5. Collot-Teixeira S., Martin J., McDermott-Roe C., Poston R., McGregor J.L. CD36 and macrophages in atherosclerosis. Cardiovasc. Res. 2007, 75:468-477.
6. Calvo D., Gómez-Coronado D., Suárez Y., Lasunción M.A., Vega M.A. Human CD36 is a high affinity receptor for the native lipoproteins HDL, LDL, and VLDL. J. Lipid Res. 1998, 39:777-788.
7. Endemann G., Stanton L.W., Madden K.S., Bryant C.M., White R.T., Protter A.A. CD36 is a receptor for oxidized low density lipoprotein. J. Biol. Chem. 1993, 268:11811-11816.
8. Park Y.M., Febbraio M., Silverstein R.L. CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima. J. Clin. Invest. 2009, 119:136-145.
9. Moore K.J., Freeman M.W. Scavenger receptors in atherosclerosis: beyond lipid uptake. Arterioscler. Thromb. Vasc. Biol. 2006, 26:1702-1711.
10. Febbraio M., Abumrad N.A., Hajjar D.P., Sharma K., Cheng W., Pearce S.F., Silverstein R.L. A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. J. Biol. Chem. 1999, 274:19055-19062.
11. Febbraio M., Podrez E.A., Smith J.D., Hajjar D.P., Hazen S.L., Hoff H.F., Sharma K., Silverstein R.L. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J. Clin. Invest. 2000, 105:1049-1056.
12. Kuchibhotla S., Vanegas D., Kennedy D.J., Guy E., Nimako G., Morton R.E., Febbraio M. Absence of CD36 protects against atherosclerosis in ApoE knock-out mice with no additional protection provided by absence of scavenger receptor A I/II. Cardiovasc. Res. 2008, 78:185-196.
13. Nakata A., Nakagawa Y., Nishida M., Nozaki S., Miyagawa J., Nakagawa T., Tamura R., Matsumoto K., Kameda-Takemura K., Yamashita S., Matsuzawa Y. CD36, a novel receptor for oxidized low-density lipoproteins, is highly expressed on lipid-laden macrophages in human atherosclerotic aorta. Arterioscler. Thromb. Vasc. Biol. 1999, 19:1333-1339.
14. Daviet L., Malvoisin E., Wild T.F., McGregor J.L. Thrombospondin induces dimerization of membrane-bound, but not soluble, CD36. Thromb. Haemost. 1997, 78:897-901.
15. Pearce S.F., Wu J., Silverstein R.L. A carboxyl terminal truncation mutant of CD36 is secreted and binds thrombospondin: Evidence for a single transmembrane domain. Blood 1994, 84:384-389.
16. Gruarin P., De Monte L., Alessio M. CD36 folding revealed by conformational epitope expression is essential for cytoadherence of Plasmodium falciparum-infected red blood cells. Parasite Immunol. 2000, 22:349-360.
17. Stewart B.W., Nagarajan S. Recombinant CD36 inhibits oxLDL-induced ICAM-1-dependent monocyte adhesion. Mol. Immunol. 2006, 43:255-267.
18. Li X., Yang J., He X.B., Ding Y., Zhao P., Liu Z., Shao H., Li Z., Zhang Y., Si S. Identification of upregulators of BMP2 expression via high-throughput screening of a synthetic and natural compound library. J. Biomol. Screen. 2009, 14:1251-1256.
19. Nieland T.J., Penman M., Dori L., Krieger M., Kirchhausen T. Discovery of chemical inhibitors of the selective transfer of lipids mediated by the HDL receptor SR-BI. Proc. Natl. Acad. Sci. USA 2002, 99:15422-15427.
20. Gao J., Xu Y.N., Yang Y., Yang Y., Zheng Z., Jiang W., Hong B., Yan X., Si S. Identification of upregulators of human ATP-binding cassette transporter A1 via high-throughput screening of a synthetic and natural compound library. J. Biomol. Screen. 2008, 13:648-656.
21. Zhang J.H., Chung T.D., Oldenburg K.R. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen. 1999, 4:67-73.
22. Nicholson A.C., Hajjar D.P. CD36, oxidized LDL, and PPARγ: Pathological interactions in macrophages and atherosclerosis. Vasc. Pharmacol. 2004, 41:139-146.
23. Sadat U., Gillard J.H., Varty K. CD36 modulation in the subintimal trapping and LDL-mediated migration of macrophages. Expert Rev. Cardiovasc. Ther. 2009, 7:587-590.
24. Lysko P.G., Weinstock J., Webb C.L., Brawner M.E., Elshourbagy N.A. Identification of a small-molecule, nonpeptide macrophage scavenger receptor antagonist. J. Pharmacol. Exp. Ther. 1999, 289:1277-1285.
25. Marleau S., Harb D., Bujold K., Avallone R., Iken K., Wang Y., Demers A., Sirois M.G., Febbraio M., Silverstein R.L., Tremblay A., Ong H. EP 80317, a ligand of the CD36 scavenger receptor, protects apolipoprotein E-deficient mice from developing atherosclerotic lesions. FASEB J. 2005, 19:1869-1871.
26. Kar N.S., Ashraf M.Z., Valiyaveettil M., Podrez E.A. Mapping and characterization of the binding site for specific oxidized phospholipids and oxidized low density lipoprotein of scavenger receptor CD36. J. Biol. Chem. 2008, 283:8765-8771.
27. Stephan Z.F., Yurachek E.C. Rapid fluorometric assay of LDL receptor activity by DiI-labeled LDL. J. Lipid Res. 1993, 34:325-330.